Covid-19 Impact on At-Home Drug of Abuse Market, Global Research Reports 2020-2021
This report covers market size and forecasts of At-Home Drug of Abuse, including the following market information:
Major competitors identified in this market include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Dr?gerwerk, Express Diagnostics, Psychemedics Corporation, Waters Corporation, BioMerieux, Roche, etc.
Based on the Region:
- Global At-Home Drug of Abuse Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global At-Home Drug of Abuse Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global At-Home Drug of Abuse Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global At-Home Drug of Abuse Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Dr?gerwerk, Express Diagnostics, Psychemedics Corporation, Waters Corporation, BioMerieux, Roche, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Consumable
- Equipment
- Urine
- Saliva
- Hair
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on At-Home Drug of Abuse Industry
1.7 COVID-19 Impact: At-Home Drug of Abuse Market Trends
2 GLOBAL AT-HOME DRUG OF ABUSE QUARTERLY MARKET SIZE ANALYSIS
2.1 At-Home Drug of Abuse Business Impact Assessment - COVID-19
2.1.1 Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global At-Home Drug of Abuse Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global At-Home Drug of Abuse Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global At-Home Drug of Abuse Factory Price by Manufacturers
3.3 Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into At-Home Drug of Abuse Market
3.5 Key Manufacturers At-Home Drug of Abuse Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON AT-HOME DRUG OF ABUSE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Consumable
1.4.2 Equipment
4.2 By Type, Global At-Home Drug of Abuse Market Size, 2019-2021
4.2.1 By Type, Global At-Home Drug of Abuse Market Size by Type, 2020-2021
4.2.2 By Type, Global At-Home Drug of Abuse Price, 2020-2021
5 IMPACT OF COVID-19 ON AT-HOME DRUG OF ABUSE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Urine
5.5.2 Saliva
5.5.3 Hair
5.5.4 Others
5.2 By Application, Global At-Home Drug of Abuse Market Size, 2019-2021
5.2.1 By Application, Global At-Home Drug of Abuse Market Size by Application, 2019-2021
5.2.2 By Application, Global At-Home Drug of Abuse Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Siemens AG
7.1.1 Siemens AG Business Overview
7.1.2 Siemens AG At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.1.3 Siemens AG At-Home Drug of Abuse Product Introduction
7.1.4 Siemens AG Response to COVID-19 and Related Developments
7.2 Danaher Corporation
7.2.1 Danaher Corporation Business Overview
7.2.2 Danaher Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.2.3 Danaher Corporation At-Home Drug of Abuse Product Introduction
7.2.4 Danaher Corporation Response to COVID-19 and Related Developments
7.3 Shimadzu Corporation
7.3.1 Shimadzu Corporation Business Overview
7.3.2 Shimadzu Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.3.3 Shimadzu Corporation At-Home Drug of Abuse Product Introduction
7.3.4 Shimadzu Corporation Response to COVID-19 and Related Developments
7.4 MilliporeSigma
7.4.1 MilliporeSigma Business Overview
7.4.2 MilliporeSigma At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.4.3 MilliporeSigma At-Home Drug of Abuse Product Introduction
7.4.4 MilliporeSigma Response to COVID-19 and Related Developments
7.5 Dr?gerwerk
7.5.1 Dr?gerwerk Business Overview
7.5.2 Dr?gerwerk At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.5.3 Dr?gerwerk At-Home Drug of Abuse Product Introduction
7.5.4 Dr?gerwerk Response to COVID-19 and Related Developments
7.6 Express Diagnostics
7.6.1 Express Diagnostics Business Overview
7.6.2 Express Diagnostics At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.6.3 Express Diagnostics At-Home Drug of Abuse Product Introduction
7.6.4 Express Diagnostics Response to COVID-19 and Related Developments
7.7 Psychemedics Corporation
7.7.1 Psychemedics Corporation Business Overview
7.7.2 Psychemedics Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.7.3 Psychemedics Corporation At-Home Drug of Abuse Product Introduction
7.7.4 Psychemedics Corporation Response to COVID-19 and Related Developments
7.8 Waters Corporation
7.8.1 Waters Corporation Business Overview
7.8.2 Waters Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.8.3 Waters Corporation At-Home Drug of Abuse Product Introduction
7.8.4 Waters Corporation Response to COVID-19 and Related Developments
7.9 BioMerieux
7.9.1 BioMerieux Business Overview
7.9.2 BioMerieux At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.9.3 BioMerieux At-Home Drug of Abuse Product Introduction
7.9.4 BioMerieux Response to COVID-19 and Related Developments
7.10 Roche
7.10.1 Roche Business Overview
7.10.2 Roche At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.10.3 Roche At-Home Drug of Abuse Product Introduction
7.10.4 Roche Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 At-Home Drug of Abuse Supply Chain Analysis
8.1.1 At-Home Drug of Abuse Supply Chain Analysis
8.1.2 Covid-19 Impact on At-Home Drug of Abuse Supply Chain
8.2 Distribution Channels Analysis
8.2.1 At-Home Drug of Abuse Distribution Channels
8.2.2 Covid-19 Impact on At-Home Drug of Abuse Distribution Channels
8.2.3 At-Home Drug of Abuse Distributors
8.3 At-Home Drug of Abuse Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on At-Home Drug of Abuse Industry
1.7 COVID-19 Impact: At-Home Drug of Abuse Market Trends
2 GLOBAL AT-HOME DRUG OF ABUSE QUARTERLY MARKET SIZE ANALYSIS
2.1 At-Home Drug of Abuse Business Impact Assessment - COVID-19
2.1.1 Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global At-Home Drug of Abuse Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global At-Home Drug of Abuse Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global At-Home Drug of Abuse Factory Price by Manufacturers
3.3 Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into At-Home Drug of Abuse Market
3.5 Key Manufacturers At-Home Drug of Abuse Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON AT-HOME DRUG OF ABUSE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Consumable
1.4.2 Equipment
4.2 By Type, Global At-Home Drug of Abuse Market Size, 2019-2021
4.2.1 By Type, Global At-Home Drug of Abuse Market Size by Type, 2020-2021
4.2.2 By Type, Global At-Home Drug of Abuse Price, 2020-2021
5 IMPACT OF COVID-19 ON AT-HOME DRUG OF ABUSE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Urine
5.5.2 Saliva
5.5.3 Hair
5.5.4 Others
5.2 By Application, Global At-Home Drug of Abuse Market Size, 2019-2021
5.2.1 By Application, Global At-Home Drug of Abuse Market Size by Application, 2019-2021
5.2.2 By Application, Global At-Home Drug of Abuse Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Siemens AG
7.1.1 Siemens AG Business Overview
7.1.2 Siemens AG At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.1.3 Siemens AG At-Home Drug of Abuse Product Introduction
7.1.4 Siemens AG Response to COVID-19 and Related Developments
7.2 Danaher Corporation
7.2.1 Danaher Corporation Business Overview
7.2.2 Danaher Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.2.3 Danaher Corporation At-Home Drug of Abuse Product Introduction
7.2.4 Danaher Corporation Response to COVID-19 and Related Developments
7.3 Shimadzu Corporation
7.3.1 Shimadzu Corporation Business Overview
7.3.2 Shimadzu Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.3.3 Shimadzu Corporation At-Home Drug of Abuse Product Introduction
7.3.4 Shimadzu Corporation Response to COVID-19 and Related Developments
7.4 MilliporeSigma
7.4.1 MilliporeSigma Business Overview
7.4.2 MilliporeSigma At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.4.3 MilliporeSigma At-Home Drug of Abuse Product Introduction
7.4.4 MilliporeSigma Response to COVID-19 and Related Developments
7.5 Dr?gerwerk
7.5.1 Dr?gerwerk Business Overview
7.5.2 Dr?gerwerk At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.5.3 Dr?gerwerk At-Home Drug of Abuse Product Introduction
7.5.4 Dr?gerwerk Response to COVID-19 and Related Developments
7.6 Express Diagnostics
7.6.1 Express Diagnostics Business Overview
7.6.2 Express Diagnostics At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.6.3 Express Diagnostics At-Home Drug of Abuse Product Introduction
7.6.4 Express Diagnostics Response to COVID-19 and Related Developments
7.7 Psychemedics Corporation
7.7.1 Psychemedics Corporation Business Overview
7.7.2 Psychemedics Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.7.3 Psychemedics Corporation At-Home Drug of Abuse Product Introduction
7.7.4 Psychemedics Corporation Response to COVID-19 and Related Developments
7.8 Waters Corporation
7.8.1 Waters Corporation Business Overview
7.8.2 Waters Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.8.3 Waters Corporation At-Home Drug of Abuse Product Introduction
7.8.4 Waters Corporation Response to COVID-19 and Related Developments
7.9 BioMerieux
7.9.1 BioMerieux Business Overview
7.9.2 BioMerieux At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.9.3 BioMerieux At-Home Drug of Abuse Product Introduction
7.9.4 BioMerieux Response to COVID-19 and Related Developments
7.10 Roche
7.10.1 Roche Business Overview
7.10.2 Roche At-Home Drug of Abuse Quarterly Production and Revenue, 2020
7.10.3 Roche At-Home Drug of Abuse Product Introduction
7.10.4 Roche Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 At-Home Drug of Abuse Supply Chain Analysis
8.1.1 At-Home Drug of Abuse Supply Chain Analysis
8.1.2 Covid-19 Impact on At-Home Drug of Abuse Supply Chain
8.2 Distribution Channels Analysis
8.2.1 At-Home Drug of Abuse Distribution Channels
8.2.2 Covid-19 Impact on At-Home Drug of Abuse Distribution Channels
8.2.3 At-Home Drug of Abuse Distributors
8.3 At-Home Drug of Abuse Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on At-Home Drug of Abuse Assessment
Table 9. COVID-19 Impact: At-Home Drug of Abuse Market Trends
Table 10. COVID-19 Impact Global At-Home Drug of Abuse Market Size
Table 11. Global At-Home Drug of Abuse Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global At-Home Drug of Abuse Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global At-Home Drug of Abuse Market Growth Drivers
Table 17. Global At-Home Drug of Abuse Market Restraints
Table 18. Global At-Home Drug of Abuse Market Opportunities
Table 19. Global At-Home Drug of Abuse Market Challenges
Table 20. Key Manufacturers At-Home Drug of Abuse Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, At-Home Drug of Abuse Market Size, 2019 (K Units) & (US$ Million)
Table 22. At-Home Drug of Abuse Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Plants
Table 24. Key Manufacturers At-Home Drug of Abuse Market Served
Table 25. Date of Key Manufacturers Enter into At-Home Drug of Abuse Market
Table 26. Key Manufacturers At-Home Drug of Abuse Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global At-Home Drug of Abuse Market Size by Type, 2020, (US$ Million)
Table 29. Global At-Home Drug of Abuse Market Size by Type, 2020 (K Units)
Table 30. Global At-Home Drug of Abuse Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global At-Home Drug of Abuse Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global At-Home Drug of Abuse Market Size by Application, 2020-2021 (K Units)
Table 33. Global At-Home Drug of Abuse Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 38. US At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 43. Germany At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 50. China At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Siemens AG Business Overview
Table 58. Siemens AG At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Siemens AG At-Home Drug of Abuse Product
Table 60. Siemens AG Response to COVID-19 and Related Developments
Table 61. Danaher Corporation Business Overview
Table 62. Danaher Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Danaher Corporation At-Home Drug of Abuse Product
Table 64. Danaher Corporation Response to COVID-19 and Related Developments
Table 65. Shimadzu Corporation Business Overview
Table 66. Shimadzu Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Shimadzu Corporation At-Home Drug of Abuse Product
Table 68. Shimadzu Corporation Response to COVID-19 and Related Developments
Table 69. MilliporeSigma Business Overview
Table 70. MilliporeSigma At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. MilliporeSigma At-Home Drug of Abuse Product
Table 72. MilliporeSigma Response to COVID-19 and Related Developments
Table 73. Dr?gerwerk Business Overview
Table 74. Dr?gerwerk At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Dr?gerwerk At-Home Drug of Abuse Product
Table 76. Dr?gerwerk Response to COVID-19 and Related Developments
Table 77. Express Diagnostics Business Overview
Table 78. Express Diagnostics At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Express Diagnostics At-Home Drug of Abuse Product
Table 80. Express Diagnostics Response to COVID-19 and Related Developments
Table 81. Psychemedics Corporation Business Overview
Table 82. Psychemedics Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Psychemedics Corporation At-Home Drug of Abuse Product
Table 84. Psychemedics Corporation Response to COVID-19 and Related Developments
Table 85. Waters Corporation Business Overview
Table 86. Waters Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Waters Corporation At-Home Drug of Abuse Product
Table 88. Waters Corporation Response to COVID-19 and Related Developments
Table 89. BioMerieux Business Overview
Table 90. BioMerieux At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. BioMerieux At-Home Drug of Abuse Product
Table 92. BioMerieux Response to COVID-19 and Related Developments
Table 93. Roche Business Overview
Table 94. Roche At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Roche At-Home Drug of Abuse Product
Table 96. Roche Response to COVID-19 and Related Developments
Table 97. At-Home Drug of Abuse Distributors List
Table 98. At-Home Drug of Abuse Customers List
Table 99. Covid-19 Impact on At-Home Drug of Abuse Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on At-Home Drug of Abuse Assessment
Table 9. COVID-19 Impact: At-Home Drug of Abuse Market Trends
Table 10. COVID-19 Impact Global At-Home Drug of Abuse Market Size
Table 11. Global At-Home Drug of Abuse Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global At-Home Drug of Abuse Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global At-Home Drug of Abuse Market Growth Drivers
Table 17. Global At-Home Drug of Abuse Market Restraints
Table 18. Global At-Home Drug of Abuse Market Opportunities
Table 19. Global At-Home Drug of Abuse Market Challenges
Table 20. Key Manufacturers At-Home Drug of Abuse Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, At-Home Drug of Abuse Market Size, 2019 (K Units) & (US$ Million)
Table 22. At-Home Drug of Abuse Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Plants
Table 24. Key Manufacturers At-Home Drug of Abuse Market Served
Table 25. Date of Key Manufacturers Enter into At-Home Drug of Abuse Market
Table 26. Key Manufacturers At-Home Drug of Abuse Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global At-Home Drug of Abuse Market Size by Type, 2020, (US$ Million)
Table 29. Global At-Home Drug of Abuse Market Size by Type, 2020 (K Units)
Table 30. Global At-Home Drug of Abuse Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global At-Home Drug of Abuse Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global At-Home Drug of Abuse Market Size by Application, 2020-2021 (K Units)
Table 33. Global At-Home Drug of Abuse Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global At-Home Drug of Abuse Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 38. US At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 43. Germany At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific At-Home Drug of Abuse Market Size, 2019-2021 (K Units)
Table 50. China At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa At-Home Drug of Abuse Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Siemens AG Business Overview
Table 58. Siemens AG At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Siemens AG At-Home Drug of Abuse Product
Table 60. Siemens AG Response to COVID-19 and Related Developments
Table 61. Danaher Corporation Business Overview
Table 62. Danaher Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Danaher Corporation At-Home Drug of Abuse Product
Table 64. Danaher Corporation Response to COVID-19 and Related Developments
Table 65. Shimadzu Corporation Business Overview
Table 66. Shimadzu Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Shimadzu Corporation At-Home Drug of Abuse Product
Table 68. Shimadzu Corporation Response to COVID-19 and Related Developments
Table 69. MilliporeSigma Business Overview
Table 70. MilliporeSigma At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. MilliporeSigma At-Home Drug of Abuse Product
Table 72. MilliporeSigma Response to COVID-19 and Related Developments
Table 73. Dr?gerwerk Business Overview
Table 74. Dr?gerwerk At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Dr?gerwerk At-Home Drug of Abuse Product
Table 76. Dr?gerwerk Response to COVID-19 and Related Developments
Table 77. Express Diagnostics Business Overview
Table 78. Express Diagnostics At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Express Diagnostics At-Home Drug of Abuse Product
Table 80. Express Diagnostics Response to COVID-19 and Related Developments
Table 81. Psychemedics Corporation Business Overview
Table 82. Psychemedics Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Psychemedics Corporation At-Home Drug of Abuse Product
Table 84. Psychemedics Corporation Response to COVID-19 and Related Developments
Table 85. Waters Corporation Business Overview
Table 86. Waters Corporation At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Waters Corporation At-Home Drug of Abuse Product
Table 88. Waters Corporation Response to COVID-19 and Related Developments
Table 89. BioMerieux Business Overview
Table 90. BioMerieux At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. BioMerieux At-Home Drug of Abuse Product
Table 92. BioMerieux Response to COVID-19 and Related Developments
Table 93. Roche Business Overview
Table 94. Roche At-Home Drug of Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Roche At-Home Drug of Abuse Product
Table 96. Roche Response to COVID-19 and Related Developments
Table 97. At-Home Drug of Abuse Distributors List
Table 98. At-Home Drug of Abuse Customers List
Table 99. Covid-19 Impact on At-Home Drug of Abuse Customers
LIST OF FIGURES
Figure 1. At-Home Drug of Abuse Product Picture
Figure 2. At-Home Drug of Abuse Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global At-Home Drug of Abuse Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global At-Home Drug of Abuse Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global At-Home Drug of Abuse Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global At-Home Drug of Abuse Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific At-Home Drug of Abuse Market Size Market Share, 2019-2021
Figure 1. At-Home Drug of Abuse Product Picture
Figure 2. At-Home Drug of Abuse Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global At-Home Drug of Abuse Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global At-Home Drug of Abuse Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global At-Home Drug of Abuse Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global At-Home Drug of Abuse Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific At-Home Drug of Abuse Market Size Market Share, 2019-2021
